DRL closes acquisition of Habitrol brand from Novartis Usha Sharma Dec 19, 2014 Dr Reddy’s Laboratories (DRL) has closed the acquisition of Habitrol brand (an over-the-counter nicotine replacement therapy…
FDA committee votes against Novartis’ multiple myeloma lead EP News Bureau Nov 7, 2014 FDA not bound to follow Committee's guidance its review of LBH589 NDA